𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Voltammetric Studies and Determination of Levodopa and Carbidopa in Pharmaceutical Products

✍ Scribed by Maria Socorro Maia Quintino; Miyuki Yamashita; Lúcio Angnes


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
112 KB
Volume
18
Category
Article
ISSN
1040-0397

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Comparison of standard carbidopa–levodop
✍ Dr. Rajesh Pahwa; Kelly Lyons; Desni McGuire; Paul Silverstein; Felix Zwiebel; M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

## Abstract We compared clinical, pharmacokinetic, and quality‐of‐life measures in patients with Parkinson's disease (PD) who were on standard carbidopa‐levodopa (Std‐L) and after conversion to sustained‐release carbidopa‐levodopa 50/200 (L‐CR). A total of 20 PD patients with motor fluctuations par

Double-blind trial of levodopa/carbidopa
✍ Robert A. Hauser; Michel Panisset; Giovanni Abbruzzese; Linda Mancione; Nalina D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie

Voltammetric Oxidation of Ambroxol and A
✍ B. Tolga Demircigil; Bengi Uslu; Yalçin Özkan; Sibel A. Özkan; Zühre Sentürk 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract A detailed study of the electrochemistry of ambroxol at a glassy carbon electrode was carried out in the pH range 1.8–11.0 in aqueous solution using cyclic and differential pulse voltammetry. The compound was oxidized irreversibly at high positive potentials resulting in the formation o

Pharmacokinetic comparison of sinemet an
✍ Dr. R. Pahwa; J. Marjama; D. McGuire; K. Lyons; F. Zwiebel; P. Silverstein; R. W 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

## Abstract We compared the pharmacokinetic and motor responses of Sinemet and Atamet (generic carbidopa/levodopa) in patients with Parkinson's disease. Thirty Parkinson's disease patients (10 previously untreated, 10 with early disease, and 10 with motor fluctuations/dyskinesia) participated in a